Revathy Nadhan to Cell Line, Tumor
This is a "connection" page, showing publications Revathy Nadhan has written about Cell Line, Tumor.
Connection Strength
0.181
-
Deciphering a GPCR-lncrna-miRNA nexus: Identification of an aberrant therapeutic target in ovarian cancer. Cancer Lett. 2024 Jun 01; 591:216891.
Score: 0.043
-
ß-hCG-induced mutant BRCA1 ignites drug resistance in susceptible breast tissue. Carcinogenesis. 2019 Nov 25; 40(11):1415-1426.
Score: 0.032
-
Brcal Defective Breast Cancer Cells Induce in vitro Transformation of Cancer Associated Fibroblasts (CAFs) to Metastasis Associated Fibroblasts (MAF). Sci Rep. 2018 09 17; 8(1):13903.
Score: 0.029
-
Proteomic Profiling of ß-hCG-Induced Spheres in BRCA1 Defective Triple Negative Breast Cancer Cells. J Proteome Res. 2018 01 05; 17(1):276-289.
Score: 0.028
-
Increased sensitivity of BRCA defective triple negative breast tumors to plumbagin through induction of DNA Double Strand Breaks (DSB). Sci Rep. 2016 05 25; 6:26631.
Score: 0.025
-
Plumbagin, a naphthaquinone derivative induces apoptosis in BRCA 1/2 defective castrate resistant prostate cancer cells as well as prostate cancer stem-like cells. Pharmacol Res. 2016 Mar; 105:134-45.
Score: 0.024